The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019

Amendment of regulation 31 (suspension or termination of clinical trial)U.K.

This section has no associated Explanatory Memorandum

12.  In regulation 31(4), omit sub-paragraphs (b), (d) and (e).

Commencement Information

I1Reg. 12 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1